Skip to main content
MedPath Trial logoMedPath TrialMedPath Trial Home
Clinical Trials/IRCT20160523028008N31
IRCT20160523028008N31RecruitingPhase 2

Investigating the effects of methylphenidate and atomoxetine on emotional intelligence, excutive function and self-efficacy of 12-18-year-old adolescents withThe effect of methylphenidate and automoxetine on emotional intelligence, executive function and self-efficacy of adolescents aged 12 to 18 years with Attention Deficit Hyperactivity Disorder (ADHD)

Hamedan University of Medical Sciences0 sites76 target enrollmentStarted: TBDLast updated:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Trial Snapshot

Phase
Phase 2
Status
Recruiting
Enrollment
76
Study OverviewEligibility CriteriaInvestigatorsRecords & IdentifiersSimilar Trials

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
12 years to 18 years (—)
Sex
All

Inclusion Criteria

  • •Consent to participation in the study by parents
  • •Ages 12 to 18 years
  • •Suffering from Attention Deficit Hyperactivity Disorder (ADHD)

Exclusion Criteria

  • •The existence of a range of psychotic disorders
  • •Autism spectrum disorders
  • •Severe physical illnesses
  • •intellectual disability

Investigators

Similar Trials

Recruiting
Phase 3
Investigating the effect of methylphenidate on the level of consciousness in loss of consciousness patients due to poisoning
IRCT20220305054196N4Shahid Beheshti University of Medical Sciences64
Recruiting
Phase 1
Evaluation of the efficacy of Methylphenidate and modafinil in the treatment of excessive daily sleepiness in patients with drug-resistant epilepsy and comparison with the control groupEpilepsy.Epilepsy and recurrent seizures
IRCT20171030037093N22Esfahan University of Medical Sciences84
Not yet recruiting
Phase 3
Investigating the effect of methylphenidate on increasing the level of consciousness in patients with hypoxic ischemic encephalopathy
IRCT20220924056025N1Qazvin Medical Sciences Research Deputy48
Recruiting
Phase 3
????? ????? ???? ??????(???????) ?? ??? ??? ??????? ??????? ?? ???? ???? ????????
IRCT20240415061495N1Oroumia University of Medical Sciences962
Completed
Phase 3
Evaluation of the effect of Methylphenidate on consciousness in patients ?with brain damage in ICBrain damage.Unspecified brain damage due to birth injuryP11.2
IRCT20141209020258N128Arak University of Medical Sciences90